Knockdown of PAK1 increases intratumor CD4+ and CD8+ TILs and eliminates the protective effect of pancreatic stellate cells (PSCs) on tumor cells, allowing them to be killed by the immune system (118). This evidence concerns the gene CD4 and neoplasm.